
Cures & Capital
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Cures & Capital
Stephan Christgau on applying the VC mindset in biotech & pharma
How do venture capitalists think? And how do they define and create value in the life science industry?
In this episode, we talk to Stephan Christgau, founding partner of Eir Ventures, about the VC mindset, investment decision-making and portfolio strategy. We dive into how VCs assess risk, balance high-stakes opportunities, and what could pharma and biotech companies learn from the VC way of doing things.
If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast
If you prefer to get the episodes as a video, you can watch our talking heads on YouTube.
If you want to connect with Stephan or read about Eir Ventures:
Linkedin: https://www.linkedin.com/in/stephan-christgau-6464392/
Eir Ventures: https://www.linkedin.com/company/eir-ventures/
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.